These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10132075)

  • 1. Improving quality of drug use through hospital directorates.
    Barber N
    Qual Health Care; 1993 Mar; 2(1):3-4. PubMed ID: 10132075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving quality of health care: the role of pharmacists.
    Barber N; Smith F; Anderson S
    Qual Health Care; 1994 Sep; 3(3):153-8. PubMed ID: 10139413
    [No Abstract]   [Full Text] [Related]  

  • 5. Caution advised with quality assurance consultants.
    Cramer RL
    Am J Hosp Pharm; 1991 Sep; 48(9):1891-2. PubMed ID: 1928124
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug committee--an example of a quality circle].
    Hammershøy E; Christensen U; Christensen I
    Ugeskr Laeger; 1991 Aug; 153(34):2330-3. PubMed ID: 1897040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mission, role, and functions of the P & T Committee.
    Bell JE; Evans PJ; Standish RC
    Hosp Formul; 1983 Jun; 18(6):639-40, 643-6. PubMed ID: 10260202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy and therapeutics committees: leadership opportunities in medication safety for medical toxicologists.
    Perrone J; Nelson LS
    J Med Toxicol; 2011 Jun; 7(2):99-102. PubMed ID: 21442385
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next step in clinical intervention programs.
    Catania HF; Yee WP; Catania PN
    Top Hosp Pharm Manage; 1992 Jan; 11(4):80-5. PubMed ID: 10128690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug management. Making introductions.
    Russell E; Bool P
    Health Serv J; 1999 Feb; 109(5643):28-9. PubMed ID: 10387432
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of pharmacotherapy: the role of pharmacy as quality assurance.
    Barnett MD; Fary D; Carroll NV; Miederhoff PA
    Top Hosp Pharm Manage; 1990 Nov; 10(3):47-56. PubMed ID: 10128578
    [No Abstract]   [Full Text] [Related]  

  • 15. Models of hospital drug policy in the UK.
    Cotter SM; McKee M
    J Health Serv Res Policy; 1997 Jul; 2(3):144-53. PubMed ID: 10180375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary challenges and novel strategies for health-system formulary management.
    Heindel GA; McIntyre CM
    Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use.
    Vargas-Rivas JE; Sabater-Hernández D; Calleja-Hernández MA; Faus MJ; Martínez-Martínez F
    Int J Clin Pharm; 2011 Oct; 33(5):719-21; author reply 722-3. PubMed ID: 21847687
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacy service: what are the goals of the pharmacy and therapeutics committee?
    Francke DE
    Hospitals; 1967 Oct; 41(20):99-100 passim. PubMed ID: 6065407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Create or strengthen the drug committee at a hospital].
    Bruneton C
    Med Trop (Mars); 2006 Dec; 66(6):569-72. PubMed ID: 17286023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance in the provision of hospital care. Medication process: who's responsible?
    Beste DF; de Leon RF
    Hospitals; 1974 Mar; 48(5):97-100. PubMed ID: 4815748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.